Allspring Global Investments’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Buy
6,469
+619
+11% +$33.6K ﹤0.01% 1470
2025
Q4
$272K Buy
+5,850
New +$262K ﹤0.01% 1532
2025
Q3
Sell
-8,425
Closed -$278K 1708
2025
Q2
$278K Sell
8,425
-327,565
-97% -$10.7M ﹤0.01% 1489
2025
Q1
$10.8M Sell
335,990
-257,533
-43% -$20.6M 0.02% 695
2024
Q4
$49.4M Buy
593,523
+246,049
+71% +$24.4M 0.08% 300
2024
Q3
$39.7M Buy
347,474
+3,922
+1% +$353K 0.06% 366
2024
Q2
$25.9M Buy
343,552
+296,164
+625% +$20.2M 0.04% 485
2024
Q1
$3.24M Buy
47,388
+24,785
+110% +$1.72M 0.01% 1062
2023
Q4
$1.42M Buy
22,603
+20,558
+1,005% +$1.07M ﹤0.01% 1253
2023
Q3
$104K Sell
2,045
-30
-1% -$1.48K ﹤0.01% 1988
2023
Q2
$104K Sell
2,075
-1,394
-40% -$66.1K ﹤0.01% 2039
2023
Q1
$130K Sell
3,469
-796
-19% -$33.8K ﹤0.01% 1948
2022
Q4
$205K Sell
4,265
-94
-2% -$3.69K ﹤0.01% 1817
2022
Q3
$104K Buy
4,359
+3,198
+275% +$81.1K ﹤0.01% 2072
2022
Q2
$25K Hold
1,161
﹤0.01% 2433
2022
Q1
$28K Buy
+1,161
New +$25.4K ﹤0.01% 2914

Other funds holding PCVX